Ads
related to: age-related macular degeneration - wet- Wet AMD FAQs
Get Answers To Frequently Asked
Questions About Wet AMD
- Appointment Tips
Get Tips And Useful Information
To Talk to your Retina Specialist
- Clinical Study Results
See The Results of A Clinical Study
To Learn More About This Treatment
- Sign Up For More Info
Sign Up Today To Receive More
Resources And Information
- Wet AMD FAQs
everydayhealth.com has been visited by 10K+ users in the past month
Search results
Actress Judi Dench says she 'can't even see' due to macular degeneration. Here's what to know about...
Yahoo Life Style via AOL· 1 day agoThe disease...BrightFocus Foundation, you have about twice the average risk of getting macular ...
Macular degeneration and floaters: What to know
Medical News Today· 2 days agoThis article discusses whether macular degeneration can cause eye floaters. This article also looks at symptoms and causes of eye floaters, diagnosis....
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 20 hours agoMerck’s venture arm was an investor in EyeBio. EyeBio’s lead drug, Restoret, is in development to...
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co...
Benzinga· 22 hours agoMerck & Co., Inc. MRK is reportedly on the verge of acquiring EyeBio, an eye drug company, for a sum...
2 Biotech Stocks to Buy in May
Motley Fool via Yahoo Finance· 5 days agoFor reference, Dupixent's sales were $11.59 billion last year. Regeneron's second-most-important product, Eylea, is at a critical point. Eylea is a...
Kodiak Sciences Inc. (NASDAQ:KOD) Receives $5.50 Average Price Target from Analysts
ETF DAILY NEWS· 6 days agoShares of Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) have received an average recommendation of “Reduce” from the seven analysts that are currently covering the company, Marketbeat.com ...
US Bancorp DE Has $4.34 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 21 hours agoUS Bancorp DE grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.7% in the 4th quarter, according to the company in its most recent disclosure with ...
Cambridge Investment Research Advisors Inc. Sells 2,003 Shares of Regeneron Pharmaceuticals, Inc....
ETF DAILY NEWS· 22 hours agoCambridge Investment Research Advisors Inc. lowered its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 19.8% during the fourth quarter, according to the company in ...
Dynamic Technology Lab Private Ltd Takes Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 7 days agoDynamic Technology Lab Private Ltd purchased a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the fourth quarter, according to the company in its most ...
Ad
related to: age-related macular degeneration - wet